Home
Live Updates
Luke Breaks Down Key Clinical Trial Updates From the 2023 ASCO Annual Meeting : comparemela.com
Luke Breaks Down Key Clinical Trial Updates From the 2023 ASCO Annual Meeting
Jason Luke, MD, FACP, discusses key takeaways from the KEYNOTE-716 and KEYNOTE-942 trials and other key updates from across the melanoma landscape presented at the 2023 ASCO Annual Meeting.
Related Keywords
Pennsylvania ,
United States ,
Jason Luke ,
Division Of Hematology Oncology ,
Cancer Immunotherapeutic Center ,
Hillman Cancer Center ,
Immunotherapy Program ,
European Medicines Agency ,
News Network ,
Cancer Center ,
Keynote 716 ,
Keynote 942 ,
2023 Asco Annual Meeting ,
The Melanoma Landscape ,
High Risk ,
Resected Melanoma ,
Final Distant Metastasis Free Survival Analysis ,
Pembrolizumab ,
Adjuvant Therapy ,
comparemela.com © 2020. All Rights Reserved.